logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
02/04/2026
The Central Bank of Turkey auctions 4 tons of gold per cycle through traditional methods for the seller's forward transactions.
Latest
1 m ago
Solana DeFi protocol Drift was hacked, with losses estimated at around $270 million.
1 m ago
In the peak season, the glass prices hit a temporary new low.
2 m ago
Institution: Risk assets may face further selling before Easter.
2 m ago
Southbound funds today saw a significant net purchase of 19.828 billion yuan. In terms of the Stock Connect (Shanghai) program, Yingfu Fund and HSBC China Enterprises received net purchases of 6.768 billion Hong Kong dollars and 1.344 billion Hong Kong dollars respectively; China National Offshore Oil Corporation had the highest net selling amount of 1.366 billion Hong Kong dollars. In terms of the Stock Connect (Shenzhen) program, Yingfu Fund and HSBC China Enterprises received net purchases of 1.778 billion Hong Kong dollars and 1.25 billion Hong Kong dollars respectively; Alibaba-W had the highest net selling amount of 259 million Hong Kong dollars.
2 m ago
Yuekang Pharmaceutical: Subsidiary YKYY018 Inhalation Nebulizer for the Treatment and Prevention of Human Parainfluenza Virus Infection Indications Approved for Clinical Trials
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.